Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/14/11/1623/477638/mdg449.pdf
Reference30 articles.
1. Polychemotherapy for early breast cancer: an overview of the randomized trials;Early Breast Cancer Trialists’ Collaborative Group;Lancet,1998
2. Meeting highlights: International Consensus Panel on the treatment of primary breast cancer;Goldhirsch;J Natl Cancer Inst,1998
3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: finding from National Surgical Adjuvant Breast and Bowel project B-18;Fischer;J Clin Oncol,1997
4. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer;Makris;Ann Oncol,1998
5. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicenter randomized trial;Mauriac;Ann Oncol,1999
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Review on Assessment of Response of Neo-Adjuvant Chemotherapy in Patients of Carcinoma Breast by High Frequency Ultrasound;Journal of Evolution of Medical and Dental Sciences;2020-12-21
2. A Feasibility Study of Neo-Adjuvant Low-Dose Fractionated Radiotherapy with Two Different Concurrent Anthracycline-Docetaxel Schedules in Stage IIA/B-IIIA Breast Cancer;Tumori Journal;2012-01
3. Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial);BMC Cancer;2011-08-04
4. Phase II Trial of Dose Dense Docetaxel Followed by FEC100 as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer;American Journal of Clinical Oncology;2010-12
5. Development of a new G-CSF product based on biosimilarity assessment;Annals of Oncology;2010-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3